A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia
Clinical trial NCT01961882 · COMPLETED
Trial details
- NCT number
- NCT01961882
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2017-11-16
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.